Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), sold 39,406 shares at $176.80 ($6.9M) on 2019-05-24, disclosed to the SEC on 2019-05-24.
Open-market sale of $6.9M SAGE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $174.05 | 7,948 | $1.4M | 20.1% |
| 2 | $175.02 | 24,966 | $4.4M | 63.4% |
| 3 | $175.79 | 3,974 | $699K | 10.1% |
| 4 | $176.80 | 2,518 | $445K | 6.5% |
| Total | $175.02 avg | 39,406 | $6.9M | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |